CLINICAL_TRIALS
withdrawal
· 2022-06-03
Clinical Trial Update: Pericapsular Nerve Group Block (PENG) for Hip Surgery [Phase 4]
Summary
Phase 4 trial of Pericapsular Nerve Group (PENG) block for hip surgery was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of California, San Diego | Conditions: Hip Arthropathy, Postoperative Pain, Acute | Phase 4 | Status: WITHDRAWN